TIAA Trust National Association acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 119,497 shares of the company’s stock, valued at approximately $19,880,000.
A number of other large investors have also recently bought and sold shares of the stock. Vanguard Group Inc. grew its holdings in Astera Labs by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after buying an additional 84,365 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Astera Labs by 4.5% during the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock worth $403,598,000 after purchasing an additional 104,935 shares during the last quarter. State Street Corp boosted its holdings in shares of Astera Labs by 9.1% during the third quarter. State Street Corp now owns 2,339,451 shares of the company’s stock worth $458,065,000 after purchasing an additional 195,992 shares during the last quarter. Amundi boosted its holdings in shares of Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. Finally, Value Aligned Research Advisors LLC boosted its holdings in shares of Astera Labs by 16.7% during the third quarter. Value Aligned Research Advisors LLC now owns 1,378,351 shares of the company’s stock worth $269,881,000 after purchasing an additional 197,320 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.
Key Stories Impacting Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: ALAB continues to benefit from bullish coverage tied to AI infrastructure growth, with recent commentary saying the company is still an early-stage AI story and that demand for its connectivity products remains strong. Astera Labs: Still An Early AI Story
- Positive Sentiment: Recent analysis highlighted that Astera Labs’ strong Q1 results, constructive Q2 guidance, and commentary around ramping products like Scorpio X-Series and PCIe offerings are helping support investor sentiment. Astera Labs jumps 9.4% as investors digest strong Q1 results and conference commentary
- Positive Sentiment: The company has also been included in speculation about potential future S&P 500 additions, which can draw extra attention from index-focused investors. Bloom Energy, Astera Labs, Alnylam, Reddit Could Be Among Next Adds to S&P 500
- Neutral Sentiment: Astera Labs’ latest short-interest data was reported as essentially flat at zero shares, so this does not appear to be a meaningful trading catalyst.
- Neutral Sentiment: Shareholders approved directors and governance measures at the annual meeting, which is supportive of corporate housekeeping but unlikely to move the stock by itself. Astera Labs Shareholders Approve Directors and Governance Measures
- Negative Sentiment: Several pieces warned that ALAB’s valuation has become stretched after its rapid rally, increasing the risk of a pullback if growth expectations cool. Soaring Astera Labs stock faces a major valuation risk: what next?
- Negative Sentiment: Analyst commentary also turned more cautious, including a Seeking Alpha piece calling the stock a potential short candidate and another downgrade note advising investors to trim exposure. Astera Labs: I’d Short It, But There’s No Catalyst – Longs, Beware Astera Labs: Take Some Chips Off The Table (Rating Downgrade)
- Negative Sentiment: Director Jack Lazar sold 10,000 shares under a pre-arranged plan, adding to the market’s awareness that insiders have been frequent sellers in recent months. Astera Labs (NASDAQ:ALAB) Director Sells $3,551,700.00 in Stock
Astera Labs Trading Down 1.3%
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s quarterly revenue was up 93.5% on a year-over-year basis. During the same period last year, the company posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current year.
Insider Buying and Selling at Astera Labs
In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director directly owned 319,863 shares of the company’s stock, valued at $34,420,457.43. This trade represents a 36.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the firm’s stock in a transaction dated Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer directly owned 4,079,322 shares in the company, valued at $702,214,489.08. This trade represents a 7.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,321,256 shares of company stock valued at $480,893,146 over the last three months. 10.40% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on ALAB. Rothschild & Co Redburn began coverage on Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective on the stock. Northland Securities lowered Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Loop Capital started coverage on Astera Labs in a research report on Thursday, March 5th. They issued a “buy” rating and a $250.00 target price on the stock. Roth Mkm reaffirmed a “buy” rating and issued a $275.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Finally, Evercore reaffirmed an “outperform” rating and issued a $297.00 target price on shares of Astera Labs in a research report on Tuesday, May 19th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $233.75.
Get Our Latest Analysis on ALAB
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
- Five stocks we like better than Astera Labs
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
